{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:16:20Z","timestamp":1758039380488,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ad.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T23:08:56Z","timestamp":1588115336000},"page":"806-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impacto de la pandemia COVID-19 en los tratamientos inmunomoduladores e inmunosupresores en dermatolog\u00eda: actitudes de los pacientes y los dermat\u00f3logos en Argentina"],"prefix":"10.1016","volume":"111","author":[{"given":"S.","family":"Zimman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Cura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.C.","family":"Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Echeverr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.D.","family":"Mazzuoccolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2020.04.004_bib0055","unstructured":"Bolet\u00edn Oficial Rep\u00fablica Argentina - Aislamiento social preventivo y obligatorio - Decreto 297\/2020 [consultado 27 Mar 2020]. Disponible en: https:\/\/www.boletinoficial.gob.ar\/detalleAviso\/primera\/227042"},{"key":"10.1016\/j.ad.2020.04.004_bib0060","unstructured":"SOARPSO. Actualizaci\u00f3n de recomendaciones coronavirus (COVID-19). En: SOARPSO [Internet] [consultado 27 Mar 2020]. Disponible en: https:\/\/www.soarpso.org\/noticia_detalle.php?IdNoticia=1427"},{"key":"10.1016\/j.ad.2020.04.004_bib0065","unstructured":"Managing your practice through the COVID-19 outbreak [consultado 27 Mar 2020]. Disponible en: https:\/\/www.aad.org\/member\/practice\/managing\/coronavirus"},{"key":"10.1016\/j.ad.2020.04.004_bib0070","unstructured":"L\u00f3pez P.P.\u00c1. Coronavirus: Los pacientes dermatol\u00f3gicos no deben suspender sus tratamientos. 24 marzo 2020. Academia Espa\u00f1ola de Dermatolog\u00eda y Venereolog\u00eda. En: Academia Espa\u00f1ola de Dermatolog\u00eda y Venereolog\u00eda [Internet] [consultado 27 Mar 2020]. Disponible en: https:\/\/aedv.es\/coronavirus-los-pacientes-dermatologicos-no-deben-suspender-sus-tratamiento\/"},{"key":"10.1016\/j.ad.2020.04.004_bib0075","article-title":"Telehealth: helping your patients and practice survive and thrive during the COVID-19 crisis with rapid quality implementation","author":"Lee","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2020.04.004_bib0080","first-page":"1","article-title":"Should patients stop their biologic treatment during the COVID-19 pandemic","author":"Bashyam","year":"2020","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2020.04.004_bib0085","doi-asserted-by":"crossref","DOI":"10.1111\/ajd.13295","article-title":"Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases","author":"Rademaker","year":"2020","journal-title":"Australas J Dermatol."},{"key":"10.1016\/j.ad.2020.04.004_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.03.031","article-title":"Should biologics for psoriasis be interrupted in the era of COVID-19?","author":"Lebwohl","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2020.04.004_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.03.046","article-title":"COVID-19 and immunomodulator\/immunosuppressant use in dermatology","author":"Price","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2020.04.004_bib0100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter","year":"2019","journal-title":"J Am Acad Dermatol."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731020301095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731020301095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:10:46Z","timestamp":1757553046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731020301095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0001731020301095"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2020.04.004","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impacto de la pandemia COVID-19 en los tratamientos inmunomoduladores e inmunosupresores en dermatolog\u00eda: actitudes de los pacientes y los dermat\u00f3logos en Argentina","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}